Coloplast A/S (CLPBF)
PNK: CLPBF
· Real-Time Price · USD
98.09
-8.16 (-7.68%)
At close: May 07, 2025, 10:10 AM
Coloplast A/S Income Statement
Financials in DKK. Fiscal
year is
October - September.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Revenue | 7.03B | 6.95B | 6.88B | 6.59B | 6.61B | 6.23B | 6.11B | 6.06B | 6.11B | 6.06B | 5.85B | 5.5B | 5.17B | 5.1B | 4.83B | 4.75B | 4.74B |
Cost of Revenue | 2.28B | 2.31B | 2.24B | 2.11B | 2.1B | 2.09B | 2.08B | 2.03B | 1.96B | 1.89B | 1.8B | 1.72B | 1.64B | 1.58B | 1.5B | 1.5B | 1.53B |
Gross Profit | 4.75B | 4.64B | 4.65B | 4.48B | 4.5B | 4.13B | 4.02B | 4.03B | 4.15B | 4.17B | 4.05B | 3.78B | 3.53B | 3.52B | 3.33B | 3.25B | 3.21B |
Operating Income | 1.91B | 1.91B | 1.83B | 1.78B | 1.82B | 1.65B | 1.71B | 1.65B | 1.76B | 1.78B | 1.74B | 1.3B | 1.61B | 1.85B | 1.59B | 1.38B | 1.54B |
Interest Income | 52M | 28M | 34M | 36M | 22M | 29M | 37M | 42M | 1M | 5M | 79M | 50M | 2M | 3M | 44M | 98M | 2M |
Pretax Income | 1.77B | 1.6B | 1.63B | 1.61B | 1.55B | 1.53B | 1.61B | 1.46B | 1.43B | 1.61B | 1.67B | 1.29B | 1.56B | 1.64B | 1.62B | 1.48B | 1.5B |
Net Income | 1.04B | 1.31B | 1.27B | 1.25B | 1.21B | 1.23B | 1.27B | 1.16B | 1.13B | 1.23B | 1.29B | 980M | 1.21B | 1.3B | 1.25B | 1.13B | 1.14B |
Selling & General & Admin | 2.62B | 2.58B | 2.55B | 2.48B | 2.46B | 2.18B | 2.13B | 2.16B | 2.16B | 2.15B | 2.08B | 1.88B | 1.69B | 1.67B | 1.58B | 1.5B | 1.5B |
Research & Development | 219M | 219M | 240M | 221M | 233M | 231M | 216M | 209M | 216M | 217M | 222M | 222M | 205M | 207M | 185M | 177M | 186M |
Other Expenses | -5M | -63M | 23M | n/a | -5M | -20M | -6M | -12M | -6M | -9M | -18M | -11M | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 2.84B | 2.73B | 2.81B | 2.7B | 2.68B | 2.42B | 2.34B | 2.36B | 2.37B | 2.36B | 2.29B | 2.1B | 1.88B | 1.87B | 1.74B | 1.67B | 1.67B |
Interest Expense | 204M | 193M | 237M | 201M | 174M | 187M | 141M | 232M | 122M | 92M | 149M | 68M | 6M | 6M | 17M | n/a | 7M |
Selling & Marketing Expenses | 2.33B | 2.29B | 2.25B | 2.15B | 2.13B | 1.91B | 1.87B | 1.88B | 1.86B | 1.87B | 1.81B | 1.62B | 1.49B | 1.45B | 1.4B | 1.32B | 1.31B |
Cost & Expenses | 5.11B | 5.05B | 5.05B | 4.81B | 4.78B | 4.51B | 4.42B | 4.39B | 4.33B | 4.25B | 4.09B | 3.82B | 3.52B | 3.45B | 3.24B | 3.18B | 3.2B |
Income Tax Expense | 725M | 289M | 357M | 355M | 342M | 298M | 338M | 306M | 300M | 382M | 382M | 307M | 350M | 339M | 365M | 345M | 359M |
Shares Outstanding (Basic) | 225.3M | 225M | 225.09M | 224.7M | 218.5M | 218.4M | 212.46M | 212.41M | 212.41M | 212.31M | 212.4M | 212.6M | 212.8M | 213.24M | 212.9M | 212.8M | 212.7M |
Shares Outstanding (Diluted) | 225.3M | 225M | 225.09M | 224.7M | 218.5M | 224.66M | 212.71M | 212.41M | 212.41M | 212.8M | 212.71M | 213.04M | 213.25M | 213.28M | 213.27M | 213.21M | 212.7M |
EPS (Basic) | 4.63 | 5.84 | 5.66 | 5.57 | 5.55 | 5.63 | 5.99 | 5.44 | 5.31 | 5.79 | 6.07 | 4.61 | 5.67 | 6.12 | 5.89 | 5.31 | 5.34 |
EPS (Diluted) | 4.63 | 5.84 | 5.66 | 5.57 | 5.55 | 5.47 | 5.98 | 5.44 | 5.31 | 5.78 | 6.06 | 4.60 | 5.66 | 6.12 | 5.88 | 5.30 | 5.34 |
EBITDA | 2.3B | 2.13B | 2.2B | 2.11B | 2.13B | 1.99B | 1.95B | 1.94B | 2.04B | 2.02B | 2.02B | 1.92B | 1.82B | 1.84B | 1.8B | 1.77B | 1.74B |
EBIT | 1.97B | 1.8B | 1.87B | 1.81B | 1.73B | 1.71B | 1.75B | 1.69B | 1.55B | 1.7B | 1.82B | 1.35B | 1.56B | 1.65B | 1.64B | 1.58B | 1.5B |
Depreciation & Amortization | 328M | 335M | 328M | 319M | 308M | 277M | 263M | 268M | 261M | 259M | 260M | 236M | 175M | 191M | 209M | 190M | 202M |